Highly multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the COLO 858 melanoma cell line - Dataset (ID:20236)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Timepoint Timepoint Unit Raw Image Registered Image CycIF Round Primary Antibody Secondary Antibody Cytell filter Protein Detected Other Reagent Detected Measured Fluorescence Intensity (a.u.) Field Cell ID Number X-coordinate Y-coordinate Cell Area (um^2) Cell Perimeter (um) Cell Circularity
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1265.6 3
0335-0673
211.95 673.34 288 68.53 0.771
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 593.7 3
0336-0672
244.53 673.82 262 64.53 0.791
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 962.2 3
0337-0678
779.05 677.79 266 59.36 0.949
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 920.4 3
0338-0679
734.95 678.14 297 63.94 0.913
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 875.5 3
0339-0681
865.04 680.29 300 66.77 0.846
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 575.7 3
0340-0682
910.16 681.82 303 65.60 0.885
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 540.2 3
0341-0682
754.15 682.31 293 63.01 0.927
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 664.8 3
0342-0681
883.02 681.72 260 61.01 0.878
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 439.9 3
0343-0681
559.94 681.50 269 63.36 0.842
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1399.3 3
0344-0687
817.17 687.40 326 67.60 0.897
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 396.7 3
0345-0688
615.97 687.25 257 61.11 0.865
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 366.8 3
0346-0694
384.31 694.38 318 68.53 0.851
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 595.9 3
0347-0697
418.34 698.00 305 66.77 0.860
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 542.5 3
0348-0701
679.16 701.08 282 67.36 0.781
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1180.1 3
0349-0701
229.03 700.26 253 67.84 0.691
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 575.0 3
0350-0705
619.82 705.13 278 63.94 0.854
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 440.0 3
0351-0702
848.61 702.61 245 59.94 0.857
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 251.3 3
0352-0709
943.83 708.13 287 64.77 0.860
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1707.5 3
0353-0709
56.23 709.62 258 61.70 0.852
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 326.3 3
0354-0711
333.46 711.20 309 69.11 0.813
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 882.7 4
0001-0023
195.30 23.30 268 61.36 0.895
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1491.2 4
0002-0022
562.22 22.54 257 61.36 0.858
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 423.8 4
0003-0021
820.66 21.45 146 46.04 0.865
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 294.2 4
0004-0026
17.68 27.12 282 63.84 0.869
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1351.7 4
0005-0025
333.33 25.35 262 59.36 0.935